| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/12/2011 | CN101032551B Hepatosis-treating Chinese traditional medicine |
| 01/11/2011 | US7868160 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867509 Fast dissolving orally consumable films |
| 01/11/2011 | CA2577310C Methods and compositions for oral delivery of fts |
| 01/11/2011 | CA2575777C Compositions and methods for treatment of colitis using methimazole and/or cyclic thione derivatives |
| 01/11/2011 | CA2534088C 2,3-substituted pryidl compounds useful for treating pain |
| 01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
| 01/11/2011 | CA2471766C Compositions for improving lipid metabolism |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2439756C Substituted aminodicarboxylic acid derivatives with pharmaceutical properties |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2372063C Pyridopyranoazepine derivatives, their preparation and their therapeutic application |
| 01/11/2011 | CA2364436C Lactic acid bacteria strains capable of preventing diarrhoea |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/06/2011 | WO2011002100A1 Medicament for the long term nsaid use |
| 01/06/2011 | WO2011002026A1 Amyloid fibril formation inhibitor and use thereof |
| 01/06/2011 | WO2011001954A1 Therapeutic agent for abnormal defecation in inflammatory bowel disease patient who is in remission phase |
| 01/06/2011 | WO2011001897A1 Medicinal agent and method for treatment of intractable chronic hepatitis c |
| 01/06/2011 | WO2011001181A1 Antimicrobial material |
| 01/06/2011 | WO2011000620A1 Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients |
| 01/06/2011 | WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors |
| 01/06/2011 | WO2010114425A3 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
| 01/06/2011 | WO2010104309A3 Compositions for preventing or improving gastrointestinal diseases |
| 01/06/2011 | WO2009144093A8 Hydroxytyrosol benefits mitochondria |
| 01/06/2011 | US20110004949 Immunoglobulin 1 |
| 01/06/2011 | US20110004948 Immunoglobulin 2 |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003890 Use of angiogenesis antagonists in conditions of abnormal venous proliferation |
| 01/06/2011 | US20110003882 RNAi Modulation of AHA and Therapeutic Uses Thereof |
| 01/06/2011 | US20110003864 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof |
| 01/06/2011 | US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003832 NEW CAPPED Pyrazinoylguanidine SODIUM CHANNEL BLOCKERS |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003823 Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage |
| 01/06/2011 | US20110003793 AZINONE-SUBSTITUTED AZEPINO[b]INDOLE AND PYRIDO-PYRROLO-AZEPINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF |
| 01/06/2011 | US20110003782 23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof |
| 01/06/2011 | US20110003768 Prebiotic compositions |
| 01/06/2011 | US20110003757 Pharmaceutical compositions for treating fatty liver disease |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003746 Protein variants |
| 01/06/2011 | US20110003741 Novel neurturin conjugates for pharmaceutical use |
| 01/06/2011 | US20110003739 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003738 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003737 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003005 Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| 01/06/2011 | US20110003002 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 01/06/2011 | US20110002996 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002965 Immunomodulating compounds and related compositions and methods |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002926 Hepatitis c virus antibodies |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002906 Purification and Isolation of Recombinant Oxalate Degrading Enzymes and Spray-Dried Particles Containing Oxalate Degrading Enzymes |
| 01/06/2011 | US20110002899 Lymph Nodes as a Site for Regeneration |
| 01/06/2011 | US20110002894 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002884 Therapeutic compounds |
| 01/06/2011 | US20110002876 Multimeric VLA-4 Antagonists Comprising Polymer Moieties |
| 01/06/2011 | CA2767105A1 Methods of stimulating liver regeneration |
| 01/06/2011 | CA2765920A1 Antimicrobial material |
| 01/06/2011 | CA2761672A1 Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270045A1 Antibodies against Clostridium difficile toxins and uses thereof |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269999A1 Method for preparing crystalline s-omeprazole strontium hydrate |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269628A2 Pancreas-specific proteins |
| 01/05/2011 | EP2269610A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 01/05/2011 | EP2268638A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 01/05/2011 | EP2268605A1 Fatty acid derivatives for oral administration endowed with high paia- tability |
| 01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
| 01/05/2011 | EP2001483B1 Use of cholest-4-ene-3-one derivatives to obtain a cytoprotective medicine |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP0968718B1 Remedies for ulcerative colitis |
| 01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
| 01/05/2011 | CN1943654B A Chinese traditional medicinal composition and its preparation method |
| 01/05/2011 | CN1868520B Compound Barbados aloe soft-capsule preparation and its preparing method |
| 01/05/2011 | CN101939306A Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 01/05/2011 | CN101939024A Compositions for the treatment of inflammation of the gastrointestinal tract |
| 01/05/2011 | CN101938985A Compositions and devices |
| 01/05/2011 | CN101938980A Oral care product and methods of use and manufacture thereof |
| 01/05/2011 | CN101938979A Oral care regimen |
| 01/05/2011 | CN101938978A Oral care product and methods of use and manufacture thereof |
| 01/05/2011 | CN101938977A Oral care product and methods of use and manufacture thereof |
| 01/05/2011 | CN101938915A Paediatric fibre mixture |
| 01/05/2011 | CN101935687A Application of IL-12p40 siRNA to promoting liver regeneration |
| 01/05/2011 | CN101935673A Method for promoting liver regeneration by adjusting GAT-1 expression |
| 01/05/2011 | CN101935624A Bacillus subtillis and method for preparing raw powder of each gram of bacillus subtillis with 1 trillion live germs |
| 01/05/2011 | CN101935603A Elapidae penis liquor and preparation method thereof |
| 01/05/2011 | CN101935358A Ganoderma lucidum polysaccharide and preparation method thereof |
| 01/05/2011 | CN101935334A Berberine glycyrrhetinic acid enantiomeric salts and preparation method and application thereof |
| 01/05/2011 | CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 01/05/2011 | CN101935310A Refining process of famotidine raw material |
| 01/05/2011 | CN101934070A Veterinary antibacterial drug composition containing lysozyme and oligosaccharide and application thereof |
| 01/05/2011 | CN101934065A Chinese herbal medicament for treating peptic ulcer |